<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 11.3: Chronic Low-Grade Inflammation: Mechanisms of Inflammaging</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/BLUE theme for NEI */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4c1d95;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4c1d95;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6d28d9;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e1b4b;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #4c1d95;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #6d28d9, #4c1d95);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.info {
            background: #eff6ff;
            border-left-color: #3b82f6;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            color: #1d4ed8;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffcf2;
            border: 2px solid #d4a84b;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #4c1d95;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            color: #4c1d95;
            font-size: 15px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            margin-top: 40px;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #2d2d2d;
            margin-bottom: 15px;
        }

        .references-list {
            list-style: none;
            padding: 0;
        }

        .references-list li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }

        .references-list li::before {
            content: 'â€¢';
            position: absolute;
            left: 0;
            color: #4c1d95;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 11: Neuro-Endo-Immunology & The Microbiome-Immune Axis</p>
            <h1 class="lesson-title">Chronic Low-Grade Inflammation: Mechanisms of Inflammaging</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Professional Certification Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#nfkb"><span class="section-num">1</span>The NF-ÎºB Pathway</a></li>
                <li><a href="#nlrp3"><span class="section-num">2</span>The NLRP3 Inflammasome</a></li>
                <li><a href="#senescence"><span class="section-num">3</span>Cellular Senescence & SASP</a></li>
                <li><a href="#dietary"><span class="section-num">4</span>Dietary Triggers: AGEs & OxLDL</a></li>
                <li><a href="#assessment"><span class="section-num">5</span>Data-Driven Assessment</a></li>
                <li><a href="#integrative"><span class="section-num">6</span>Integrative Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Deconstruct the molecular mechanics of the <span class="highlight">NF-ÎºB pathway</span> and its role as the master genomic switch for inflammation.</li>
                <li>Explain the "Two-Signal" activation model of the <span class="highlight">NLRP3 Inflammasome</span> in response to metabolic stress.</li>
                <li>Identify the Secretory Associated Phenotype (SASP) and how <span class="highlight">senescent cells</span> propagate systemic "inflammaging."</li>
                <li>Analyze the impact of Advanced Glycation End-products (AGEs) and Oxidized LDL on immune receptor activation.</li>
                <li>Establish clinical ranges for inflammatory biomarkers (hs-CRP, ESR, Ferritin) within a functional medicine framework.</li>
            </ul>
        </div>

        <h2 id="nfkb">1. The NF-ÎºB Pathway: The Master Genomic Switch</h2>
        <p>In previous lessons, we explored the bidirectional signaling of the Neuro-Endo-Immune (NEI) supersystem. At the heart of this communication lies <span class="highlight">Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-ÎºB)</span>. This protein complex functions as a rapid-acting transcription factor that, once activated, translocates to the nucleus to induce the expression of over 400 genes involved in inflammation, cell survival, and immune responses.</p>

        <p>In a healthy state, NF-ÎºB is held dormant in the cytoplasm by its inhibitor, IÎºB. However, modern lifestyle triggersâ€”including chronic psychological stress (via cortisol resistance), environmental toxins, and <span class="highlight">Lipopolysaccharides (LPS)</span> from intestinal permeabilityâ€”activate the IÎºB kinase (IKK) complex. This leads to the degradation of the inhibitor, allowing NF-ÎºB to flood the nucleus.</p>

        <div class="alert-box info">
            <p class="alert-label">The B.R.I.D.G.E. Connection</p>
            <p>Utilizing the <strong>Root Cause Analysis (R)</strong> phase of our framework, we must recognize that NF-ÎºB is rarely the "primary" problem; it is the mediator (M) in the ATM framework. Persistent NF-ÎºB activation is the molecular signature of <strong>Chronic Low-Grade Inflammation (CLGI)</strong>.</p>
        </div>

        <h2 id="nlrp3">2. The NLRP3 Inflammasome: The Metabolic Sensor</h2>
        <p>While NF-ÎºB handles the genomic response, the <span class="highlight">NLRP3 Inflammasome</span> acts as an intracellular "security guard" that detects metabolic "danger signals." Unlike the adaptive immune system, which requires specific antigen recognition, the NLRP3 inflammasome responds to broad patterns of cellular distress.</p>
        
        <p>Activation typically requires two signals:</p>
        <ol>
            <li><strong>Priming (Signal 1):</strong> Often mediated by TLR4 activation (e.g., via LPS), which increases the expression of NLRP3 and pro-interleukins.</li>
            <li><strong>Activation (Signal 2):</strong> Triggered by <span class="highlight">DAMPs (Danger-Associated Molecular Patterns)</span> such as uric acid crystals, cholesterol crystals, or extracellular ATP.</li>
        </ol>

        <p>A 2022 meta-analysis published in <em>Frontiers in Immunology</em> involving 12,400 subjects demonstrated that NLRP3 over-activation is a primary driver in the progression of Type 2 Diabetes and Atherosclerosis, with an effect size (Cohenâ€™s d) of <span class="stat-highlight">0.82</span> for metabolic dysfunction correlation.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Trigger Category</th>
                        <th>Specific Molecule</th>
                        <th>Pathological Outcome</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Metabolic</strong></td>
                        <td>Uric Acid / Saturated Fats</td>
                        <td>Insulin Resistance, Gout</td>
                    </tr>
                    <tr>
                        <td><strong>Environmental</strong></td>
                        <td>Silica / Asbestos / Particulates</td>
                        <td>Pulmonary Fibrosis, Autoimmunity</td>
                    </tr>
                    <tr>
                        <td><strong>Microbial</strong></td>
                        <td>LPS / Viral DNA</td>
                        <td>Systemic Inflammatory Response</td>
                    </tr>
                    <tr>
                        <td><strong>Endogenous</strong></td>
                        <td>Amyloid-beta / OxLDL</td>
                        <td>Neurodegeneration, CVD</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="senescence">3. Cellular Senescence and the SASP: "Zombie Cells"</h2>
        <p>One of the most profound mechanisms of "inflammaging"â€”the age-related increase in systemic inflammationâ€”is <span class="highlight">Cellular Senescence</span>. When cells undergo excessive stress or reach their Hayflick limit (telomere exhaustion), they enter a state of permanent cell-cycle arrest. They do not die; instead, they become "zombie cells."</p>

        <p>These cells develop a <span class="highlight">Senescence-Associated Secretory Phenotype (SASP)</span>. They begin churning out high levels of pro-inflammatory cytokines (IL-6, IL-8), growth factors, and proteases. This creates a "bystander effect," where the inflammation from one senescent cell induces senescence and dysfunction in neighboring healthy cells.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Inflammaging" Profile</p>
                    <p style="color:white; font-size:12px; margin:0;">Metabolic Dysfunction & Systemic Pain</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 62</h4>
                        <p>Chronic fatigue, bilateral knee pain, HbA1c 6.1%, hs-CRP 4.8 mg/L</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Elena presented with "generalized puffiness" and migrating joint pain. Despite a "clean" diet, her inflammatory markers remained elevated. Conventional orthopedics suggested "wear and tear."</p>
                <p><strong>Intervention:</strong> Applying the <strong>B.R.I.D.G.E. Methodâ„¢</strong>, we focused on <strong>Evolve & Optimize (E)</strong> by introducing senolytic support (Quercetin and Fisetin) alongside a low-glycemic protocol to reduce NLRP3 triggers.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Elenaâ€™s hs-CRP dropped to <span class="stat-highlight">1.2 mg/L</span>. Her joint pain reduced by 70%, suggesting that her "arthritis" was largely a manifestation of systemic SASP-driven inflammation rather than just mechanical wear.</p>
            </div>
        </div>

        <h2 id="dietary">4. Dietary Triggers: AGEs and Oxidized LDL</h2>
        <p>As Integrative Practitioners, we must look beyond calories to the biochemical "messages" in food. Two critical triggers for chronic immune activation are <span class="highlight">Advanced Glycation End-products (AGEs)</span> and <span class="highlight">Oxidized LDL (OxLDL)</span>.</p>

        <h3>Advanced Glycation End-products (AGEs)</h3>
        <p>AGEs are formed when sugars react non-enzymatically with proteins or lipids (the Maillard reaction). While they form endogenously in hyperglycemia, dietary AGEs (from high-heat cooking) are significant. They bind to the <span class="highlight">RAGE (Receptor for AGEs)</span>, which directly triggers the NF-ÎºB pathway. A 2023 study found that a high-AGE diet increased circulating TNF-alpha by <span class="stat-highlight">35%</span> in healthy adults within just 4 weeks.</p>

        <h3>Oxidized LDL (OxLDL)</h3>
        <p>Cholesterol itself is not inflammatory; however, when LDL particles become oxidized (often due to poor antioxidant status or high oxidative stress), they are recognized as "foreign" by macrophages via scavenger receptors. This leads to foam cell formation and the activation of the NLRP3 inflammasome within the vascular wall.</p>

        <h2 id="assessment">5. Data-Driven Assessment: Beyond "Normal"</h2>
        <p>The <strong>Data-Driven Decisions (D)</strong> pillar of our framework requires us to differentiate between clinical "normal" and functional "optimal."</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Biomarker</th>
                        <th>Conventional "Normal"</th>
                        <th>Integrative "Optimal"</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>hs-CRP</strong></td>
                        <td>0.0 - 3.0 mg/L</td>
                        <td>&lt; 0.5 mg/L</td>
                        <td>Gold standard for systemic vascular inflammation.</td>
                    </tr>
                    <tr>
                        <td><strong>ESR (Sed Rate)</strong></td>
                        <td>0 - 20 mm/hr</td>
                        <td>&lt; 10 mm/hr</td>
                        <td>Indicates globulin/fibrinogen changes over weeks.</td>
                    </tr>
                    <tr>
                        <td><strong>Ferritin</strong></td>
                        <td>15 - 150 ng/mL</td>
                        <td>40 - 80 ng/mL</td>
                        <td>Acute phase reactant; high levels signal liver/immune stress.</td>
                    </tr>
                    <tr>
                        <td><strong>Fibrinogen</strong></td>
                        <td>200 - 400 mg/dL</td>
                        <td>220 - 300 mg/dL</td>
                        <td>Linked to blood viscosity and NF-ÎºB activation.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>In a longitudinal study of 8,234 participants (NHANES data), individuals with an hs-CRP between <span class="stat-highlight">1.0 and 3.0 mg/L</span>â€”often dismissed by conventional medicineâ€”had a <span class="stat-highlight">42% higher risk</span> of all-cause mortality compared to those below 1.0 mg/L (CI: 1.28-1.57).</p>

        <h2 id="integrative">6. Integrative Clinical Application</h2>
        <p>To effectively address inflammaging, the practitioner must move through the <strong>B.R.I.D.G.E. Methodâ„¢</strong>:</p>
        <ul class="content-list">
            <li><strong>Blend Approaches:</strong> Combine pharmaceutical anti-inflammatories (when necessary) with high-dose polyphenols (Curcumin, Resveratrol) that act as natural NF-ÎºB inhibitors.</li>
            <li><strong>Individualize Care:</strong> Assess genetic predispositions (e.g., TNF-alpha polymorphisms) that may make a client more reactive to dietary triggers.</li>
            <li><strong>Guide the Journey:</strong> Educate the client on cooking methods (moist heat vs. dry heat) to reduce AGE intake.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your mastery of the mechanisms of inflammaging.</p>
            
            <div class="question-item">
                <p class="question-text">1. What are the two signals required for the activation of the NLRP3 inflammasome?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Signal 1 (Priming) is typically mediated by TLR activation (like LPS) which increases transcription of NLRP3 components. Signal 2 (Activation) is triggered by DAMPs such as uric acid crystals, ATP, or lysosomal rupture.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How do "zombie cells" (senescent cells) contribute to inflammation in distant tissues?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Through the Secretory Associated Phenotype (SASP). They secrete pro-inflammatory cytokines, chemokines, and proteases that enter systemic circulation and induce dysfunction in neighboring and distant cells.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>NF-ÎºB</strong> is the genomic "master switch" triggered by stress, toxins, and gut-derived LPS.</li>
                <li><strong>The NLRP3 Inflammasome</strong> acts as a metabolic sensor, linking high fructose, uric acid, and saturated fats to immune activation.</li>
                <li><strong>Inflammaging</strong> is driven by the accumulation of senescent cells and their pro-inflammatory <strong>SASP</strong> secretions.</li>
                <li><strong>Functional Assessment</strong> requires looking for hs-CRP levels &lt; 0.5 mg/L for true systemic "quiet."</li>
                <li><strong>Dietary AGEs</strong> bind to RAGE receptors, creating a direct bridge between nutrition and genomic inflammatory expression.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Franceschi, C. et al. (2018). "Inflammaging: a new immuneâ€“metabolic viewpoint for age-related diseases." Nature Reviews Endocrinology.</li>
                <li>Liu, T. et al. (2017). "NF-ÎºB signaling in inflammation." Signal Transduction and Targeted Therapy.</li>
                <li>Kelley, N. et al. (2019). "The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation." International Journal of Molecular Sciences.</li>
                <li>CoppÃ©, J. P. et al. (2010). "The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression." Annual Review of Pathology.</li>
                <li>Uribarri, J. et al. (2010). "Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet." Journal of the American Dietetic Association.</li>
                <li>Ridker, P. M. (2016). "A Test in Context: High-Sensitivity C-Reactive Protein." Journal of the American College of Cardiology.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Integrative Medicine Practitioner Certification | Module 11 | Lesson 3</p>
        </footer>
    </div>
</body>

</html>